Kissei Pharmaceutical Co., Ltd. (4547.T)

JPY 3515.0

(0.14%)

Total Debt Summary of Kissei Pharmaceutical Co., Ltd.

  • Kissei Pharmaceutical Co., Ltd.'s latest annual total debt in 2023 was 1.72 Billion JPY , up 15.91% from previous year.
  • Kissei Pharmaceutical Co., Ltd.'s latest quarterly total debt in 2024 Q1 was 1.34 Billion JPY , down -22.41% from previous quarter.
  • Kissei Pharmaceutical Co., Ltd. reported annual total debt of 1.49 Billion JPY in 2022, down -9.15% from previous year.
  • Kissei Pharmaceutical Co., Ltd. reported annual total debt of 1.64 Billion JPY in 2021, down -5.91% from previous year.
  • Kissei Pharmaceutical Co., Ltd. reported quarterly total debt of 1.34 Billion JPY for 2024 Q1, down -22.41% from previous quarter.
  • Kissei Pharmaceutical Co., Ltd. reported quarterly total debt of 1.72 Billion JPY for 2023 Q4, up 24.24% from previous quarter.

Annual Total Debt Chart of Kissei Pharmaceutical Co., Ltd. (2023 - 2004)

Historical Annual Total Debt of Kissei Pharmaceutical Co., Ltd. (2023 - 2004)

Year Total Debt Total Debt Growth
2023 1.72 Billion JPY 15.91%
2022 1.49 Billion JPY -9.15%
2021 1.64 Billion JPY -5.91%
2020 1.74 Billion JPY -0.91%
2019 1.75 Billion JPY -52.38%
2018 3.69 Billion JPY 1.68%
2017 3.63 Billion JPY 5.12%
2016 3.45 Billion JPY 4.63%
2015 3.3 Billion JPY 0.76%
2014 3.27 Billion JPY -0.06%
2013 3.28 Billion JPY -6.98%
2012 3.52 Billion JPY -3.34%
2011 3.64 Billion JPY -10.87%
2010 4.09 Billion JPY 16.71%
2009 3.5 Billion JPY 8.14%
2008 3.24 Billion JPY -78.13%
2007 14.82 Billion JPY 0.41%
2006 14.76 Billion JPY -39.85%
2005 24.54 Billion JPY 1.48%
2004 24.19 Billion JPY 0.0%

Peer Total Debt Comparison of Kissei Pharmaceutical Co., Ltd.

Name Total Debt Total Debt Difference
Pharma Foods International Co., Ltd. 16.89 Billion JPY 89.776%
Takeda Pharmaceutical Company Limited 4843.75 Billion JPY 99.964%
Sumitomo Pharma Co., Ltd. 418.88 Billion JPY 99.588%
Shionogi & Co., Ltd. 11.62 Billion JPY 85.138%
Wakamoto Pharmaceutical Co.,Ltd. 100.52 Million JPY -1617.912%
Nippon Shinyaku Co., Ltd. 2.87 Billion JPY 39.868%
Kaken Pharmaceutical Co., Ltd. 3.85 Billion JPY 55.143%
Eisai Co., Ltd. 206.74 Billion JPY 99.165%
Morishita Jintan Co., Ltd. 425 Million JPY -306.353%
Hisamitsu Pharmaceutical Co., Inc. 2.1 Billion JPY 17.762%
Mochida Pharmaceutical Co., Ltd. 369 Million JPY -368.022%
Fuso Pharmaceutical Industries,Ltd. 12.72 Billion JPY 86.425%
Nippon Chemiphar Co., Ltd. 16.98 Billion JPY 89.83%
Tsumura & Co. 79.69 Billion JPY 97.833%
Torii Pharmaceutical Co., Ltd. 244 Million JPY -607.787%
Towa Pharmaceutical Co., Ltd. 202.35 Billion JPY 99.147%
Fuji Pharma Co., Ltd. 28.94 Billion JPY 94.034%
Zeria Pharmaceutical Co., Ltd. 47.58 Billion JPY 96.371%
KYORIN Holdings, Inc. 20.94 Billion JPY 91.755%
Taiko Pharmaceutical Co.,Ltd. 3.8 Billion JPY 54.66%
Daito Pharmaceutical Co.,Ltd. 8.71 Billion JPY 80.193%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 60 Million JPY -2778.333%
Modalis Therapeutics Corporation 412.5 Million JPY -318.667%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.48 Billion JPY 81.792%
Sawai Group Holdings Co., Ltd. 82.89 Billion JPY 97.917%
Cyfuse Biomedical K.K. 913 Million JPY -89.157%
Toho Holdings Co., Ltd. 30.24 Billion JPY 94.29%
Koa Shoji Holdings Co.,Ltd. 2.82 Billion JPY 38.873%